Lyme Lab
Lyme disease (LD) is a zoonotic tick-borne illness caused by the
spirochetal bacterium Borrelia burgdorferi and it is
the most prevalent arthropod-borne infection in the United States.
A total of 22,572 human cases of Lyme disease were reported to the
Centers for Disease Control and Prevention (CDC) in 2010. Dogs,
cats, horses, and cattle can also suffer from LD. Infected tick
vectors transmit the LD causative agent while biting humans and
susceptible domestic animal species [1-3]. A
significant increase in the number of reported cases has been
observed in the past few years, classifying Lyme disease as a
re-emerging infection. Lyme borreliosis is, therefore, an important
public health issue particularly in endemic areas where it
contributes to significant rates of morbidity. Lyme
disease occurs as a multi-systemic disorder leading to carditis
(10% of untreated adults), arthritis (60% of the cases) and other
neurological symptoms. Moreover, there are few therapeutic
solutions for Lyme disease patients and there are no effective
vaccines available on the market.
Nevertheless the presence of Lyme disease in Texas is not clear.
Even though there are about 100 LD cases reported to CDC every
year, it is not well understood how the disease is distributed in
Texas and what mammalian, reptile and/or bird species are involved
in maintaining its enzootic cycle. There are many questions to
answer and we would like to be part of the discovery process.
Borrelia burgdorferi, the causative agent of Lyme
disease is a gram-negative microaerophilic spirochaete that is
transmitted to the mammalian host through the bite of an infected
Ixodes ticks. The competent vector for the
transmission of the disease to humans and companion animals
described to date are
- Ixodes scapularis: will transmit Lyme disease in
most of the US
- Ixodes pacificus: will transmit Lyme disease in
the pacific coast
- Ixodes ricinus: will transmit the disease in
Europe
- Ixodes persulcatus: will transmit the disease in
Europe
Our interest is mainly directed toward understanding the
distribution of infected ticks in Texas as well as in the
development of a pan-specific Lyme test for use in Veterinary
medicine and surveillance programs. Putting these two efforts
together our goal is to map the state of Texas to determine where
are the high-risk areas for Lyme disease transmission. Moreover, we
are interested in the identification of new vaccine targets to
prevent Lyme disease. As part of this effort we are trying to
sequence the gene expression of this bacterium at different time
points during the infection process by means of Next Generation
Sequencing such as the Ilumina technology. Visit our project
section to find out more about these projects.